L. Lagrost et al., IMMUNOSPECIFIC SCINTILLATION PROXIMITY ASSAY OF CHOLESTERYL ESTER TRANSFER PROTEIN-ACTIVITY, Clinical chemistry, 41(6), 1995, pp. 914-919
We describe a novel, immunospecific scintillation proximity assay for
determining cholesteryl ester transfer protein (CETP) activity in tota
l human serum and in reconstituted experimental mixtures. The assay is
based on the measurement of radiolabeled cholesteryl esters transferr
ed from a tracer dose of biosynthetically labeled high-density lipopro
tein subfraction 3 to unlabeled apolipoprotein (ape) B-containing lipo
proteins. The radioactivity content of the apo B-containing lipoprotei
n fraction can be evaluated without separating the donor from the acce
ptor lipoprotein substrates, and is measured through the formation of
ternary complexes involving the radiolabeled apo B-containing lipoprot
eins, specific antiapo B antibodies from sheep, and anti-sheep antibod
y-labeled fluoromicrospheres. Good correspondences were observed betwe
en CETP activity values obtained either with the ultracentrifugation m
ethod or the immunospecific scintillation proximity assay (n = 70; r =
0.94; P = 0.0001), and between values obtained for either fresh or fr
ozen serum samples (n = 70; r = 0.93; P = 0.0001). Because of its pote
ntial for automation, the immunospecific scintillation proximity assay
may constitute a convenient tool to measure serum CETP activity in th
e clinical laboratory.